Dr Ash Ramzan has been invited to present “Regulatory strategies to gain early approval in different markets: understanding the U.S & EU approach compared to MENA region“ at the Bio Conference, CPhI Istanbul 2017 being held in March.
The conference will cover the latest trends and developments in Biologics, Biosimilars and Biobetters and is the only event in the region to deliver critical insights needed to navigate the evolving regulatory, strategic and technical landscape of this rapidly developing market.
CPhI and the Bio Conference will cover some of the most pressing industry challenges and will bring the pharma community together, to reaffirm and optimise existing relationships and create new strategic alliances to ensure future industry success.
Mix with the world of Pharma products, people & solutions
8-10 March 2017
Istanbul Expo Centre (IFM), Istanbul – Turkey